Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marion D. Cruchant"'
Autor:
Jean-Pierre Bergerat, Marion D. Cruchant, Brigitte Duclos, Philippe Erbs, Eva Erdmann, Dominique Chopin, Didier Jacqmin, Jocelyn Céraline, Jean-Emmanuel Kurtz
Publikováno v:
International Journal of Cancer. 108:152-157
Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgen-dependent to androgen-independent grow
Autor:
Pascal Kessler, Gemma Marcias, Eva Erdmann, Jocelyn Céraline, Gaëlle Lapouge, Marion D. Cruchant, Sebastian Serra, Jean-Pierre Bergerat
Publikováno v:
Hormonal Carcinogenesis V ISBN: 9780387690780
Mutations in the human androgen receptor (AR) gene that lead to C-terminus truncated AR variants are frequently detected in prostate cancer (PC). These AR variants lack both the ligand-binding domain (LBD) and the AF-2 region. The aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6590fe42297f6b483bb2c879beb90d49
https://doi.org/10.1007/978-0-387-69080-3_53
https://doi.org/10.1007/978-0-387-69080-3_53
Autor:
Patrick Dufour, Eva Erdmann, Dominique Chopin, Marion D. Cruchant, Jean-Pierre Bergerat, Brigitte Duclos, Philippe Erbs, Jocelyn Ceraline, Jean-Emmanuel Kurtz, Didier Jacqmin
Publikováno v:
Hormonal Carcinogenesis IV ISBN: 0387237836
Human androgen receptor (AR) mutation is a possible alternative used by prostate adenocarcinoma (PCA) cells to escape androgen dependence. These mutations may broaden the specificity and/or the sensitivity of the AR to other hormones, resulting in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39e39ca8e6521cc7dc514ee9d34c7ee6
https://doi.org/10.1007/0-387-23761-5_31
https://doi.org/10.1007/0-387-23761-5_31
Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer
Autor:
Audrey Monge, Jocelyn Céraline, J-M Wurtz, Monika Jagla, Marion D. Cruchant, Gaëlle Lapouge, J. P. Bergerat, S Sasorith, Didier Jacqmin
Publikováno v:
Cellular and Molecular Life Sciences
Cellular and Molecular Life Sciences, Springer Verlag, 2006, 63 (4), pp.487-97. ⟨10.1007/s00018-005-5471-y⟩
Cellular and Molecular Life Sciences, Springer Verlag, 2006, 63 (4), pp.487-97. ⟨10.1007/s00018-005-5471-y⟩
International audience; Missense mutations in the androgen receptor (AR) contribute to the failure of hormonal therapy for prostate cancer (PCa), but the underlying molecular bases remain uncharacterized. Here, we describe a new AR variant found in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3faad3260c2f1a668b0617ac14c1cc3f
https://hal.archives-ouvertes.fr/hal-00188044
https://hal.archives-ouvertes.fr/hal-00188044
Autor:
Jocelyn, Céraline, Marion D, Cruchant, Eva, Erdmann, Philippe, Erbs, Jean-Emmanuel, Kurtz, Brigitte, Duclos, Didier, Jacqmin, Dominique, Chopin, Jean-Pierre, Bergerat
Publikováno v:
International journal of cancer. 108(1)
Androgen receptor (AR) mutations that modify both the ligand binding and the transactivation capacities of the AR represent one of the mechanisms involved in the transition of prostate cancer (PCa) from androgen-dependent to androgen-independent grow
Autor:
Jocelyn Céraline, Marion D. Cruchant, Eva Erdmann, Philippe Erbs, Jean-Emmanuel Kurtz, Brigitte Duclos, Didier Jacqmin, Dominique Chopin, Jean-Pierre Bergerat
Publikováno v:
International Journal of Cancer; 1/1/2004, Vol. 108 Issue 1, p152, 6p